what glp-1 does medicare cover GLP-1's and Navigating Medicare coverage for prescription

Seems more of an indication of the level they might question

In 2024, Sakuma et al., in Japan, carried out a clinical study to evaluate the effects of cysteine peptides, which included both reduced glutathione (GSH) and oxidized glutathione (GSSG), over 5 weeks

The not for human consumption label is not a warning, it is a legal shield: it lets a supplier sell a compound for injection while formally disclaiming that it is for injection, which conveniently also exempts it from the testing a drug for injection would require

However, the effects of combinations of multi-receptor agonists in humans can be challenging to predict from animal studies [68]